Global cardiovascular giant Boston Scientific's development in China has reached an important milestone. A reporter from Pengpai News learned from the Lingang Group that on October 15, Boston Scientific China's first manufacturing base opened in the Lingang New Area Life Blue Bay Pharmaceutical Specialty Industrial Park. An Bocheng, executive vice president of Boston Scientific Global and president of the Medical Surgery and Asia Pacific Group, said that the Lingang plant is an important step for Boston Scientific to take root in China for a long time and integrate into the local medical industry chain. “In the future, Boston Scientific will be here to produce more high-quality innovative medical products that meet the urgent needs of Chinese doctors and patients.” At the same time, Boston Scientific will continue to invest more in China and actively cooperate with local suppliers to provide much-needed innovative medical products for Chinese doctors and patients with high incidence diseases with new quality productivity.

Zhitongcaijing · 10/15 12:17
Global cardiovascular giant Boston Scientific's development in China has reached an important milestone. A reporter from Pengpai News learned from the Lingang Group that on October 15, Boston Scientific China's first manufacturing base opened in the Lingang New Area Life Blue Bay Pharmaceutical Specialty Industrial Park. An Bocheng, executive vice president of Boston Scientific Global and president of the Medical Surgery and Asia Pacific Group, said that the Lingang plant is an important step for Boston Scientific to take root in China for a long time and integrate into the local medical industry chain. “In the future, Boston Scientific will be here to produce more high-quality innovative medical products that meet the urgent needs of Chinese doctors and patients.” At the same time, Boston Scientific will continue to invest more in China and actively cooperate with local suppliers to provide much-needed innovative medical products for Chinese doctors and patients with high incidence diseases with new quality productivity.